MedTrace Logo

Efficacy of a Deep Cleansing Gel Containing 2% Salicylic Acid, 0.2% Zinc Gluconate and 0.05% Lipohydroxy Acid in the Management of Mild to Moderate Facial Acne

NCT05779085 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56

Last updated 2023-03-22

No results posted yet for this study

Summary

A clinical study with 56 healthy subjects (both sexes) aged between 13 to 25 years old. Subjects enrolled had a minimum of 5 inflammatory lesions (papules, nodules and pustules) and 10 non-inflammatory lesions (open and closed comedones), determined by dermatologist. The clinical evaluation considered in oiliness, shininess and global aspect of the skin too. Instrumental assessment of oiliness and shininess was performed, respectively, by Sebumeter and Sebutape.

IThe tested cleanser was used twice daily (morning and evening) during 28 days.

Conditions

  • Acne Vulgaris on the Face

Interventions

OTHER

Dermocosmetic

Use of daily cleanser to treat facial acne

Sponsors & Collaborators

  • Cosmetique Active International

    lead INDUSTRY

Eligibility

Min Age
13 Years
Max Age
26 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-08
Primary Completion
2013-07-22
Completion
2013-07-22

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05779085 on ClinicalTrials.gov